Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Phase III Study Showed Lucentis Improved Vision In Patients With Branch Retinal Vein Occlusion
Genentech, Inc. announced today that the Phase III study BRAVO showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion. The safety profile of Lucentis was consistent with previous experience and no new adverse events related to Lucentis were observed in the study. Retinal vein occlusion (RVO) is a common cause of vision loss that occurs when blood flow through a retinal vein becomes blocked, such as by a blood clot.
generic viagra online
Human Genome Sciences And GlaxoSmithKline Announce Positive Phase 3 Study Results For BENLYSTA(TM) In Systemic Lupus Erythematosus
Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) announced that BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). In the placebo-controlled BLISS-52 study, the results showed that belimumab plus standard of care achieved a clinically and statistically significant improvement in patient response rate at Week 52, compared with standard of care alone. Study results also showed that belimumab was generally well tolerated, with adverse event rates comparable between belimumab and placebo treatment groups.
News of the day
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate And Treatment Failure In Patients With Chronic ITP
Amgen Inc. (Nasdaq: AMGN) today released the results of a new study comparing Nplate(R) (romiplostim) to the medical standard of care (SOC) in non-splenectomised adult patients with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a serious autoimmune disorder characterised by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. The study results show Nplate significantly reduced the incidences of splenectomy and treatment failures in non-splenectomised adult patients with chronic ITP when compared to medical SOC. The results were presented today as an oral presentation at the 14th congress of the European Hematology Association (EHA abstract #1672).
Medical Devices

Seeking Solutions To The Chronic Nursing Shortage In Canada And The US

The Arthur Labatt Family School of Nursing at The University of Western Ontario has announced a $2 million research chair to address issues surrounding the chronic shortage of registered nurses in Canada and the United States. Dr. Heather Laschinger, Ph.D., was named the first Arthur Labatt Family Nursing Research Chair in Human Re Optimization. A study by the Canadian Nurses Association found the country will be short 78,000 registered nurses (RNs) within two years, and the number is expected to grow to 113,000 by 2016. The American Nurses Association says the shortage in the US will be more than one million nurses by the end of this decade. The Arthur Labatt Family Nursing Research Chair in Human Re Optimization will lead a broad research agenda examining issues related to the education and retention of nurses and factors that contribute to their success in a variety of health care settings, and support related teaching initiatives. The Chair"s research will focus on the causes and consequences of the current professional nursing workforce shortage, with a view to optimizing health human res in nursing to ensure high quality health care. Laschinger says she"s thrilled to be selected for this new research chair. "The Chair will extend my ongoing research, which for the past 15 years has examined how best to empower nurses for excellence in professional practice in work environments that promote the health of both nurses and their patients," says the Associate Director, Nursing Research and Distinguished University Professor. "This will provide an opportunity to develop new directions for investigating ways to optimize nurses" scope of practice within current evolving interprofessional practice environments and to examine best educational practices that prepare new graduates for optimal role functioning in these challenging work settings." "Research excellence is critically important and I see this appointment as a way of advancing research in our strong School of Nursing. This Chair is focused in a timely, and critically important area for the Faculty and our society," says Jim Weese, Dean of the Faculty of Health Sciences. "I congratulate Dr. Laschinger on being the inaugural Arthur Labatt Family Nursing Research Chair in Human Re Optimization and I know that the outcomes of her research will continue to make a difference in the area." The Research Chair is part of a $10 million gift from Arthur and Sonia Labatt announced last year. Kathy Wallis University of Western Ontario


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009